- Liquid Biopsy
- Gene Panel
- Laboratory-developed test (LDT)
- Others
Early Cancer Detection Market size was valued at USD 955.3 million in 2023 and grew at 13.1% CAGR from 2024-2030. The Early Cancer Detection Market is projected to create an opportunity of around US$ 1,200 Million in 2030. The multi-cancer early detection market has seen significant expansion due to greater awareness, and the government's emphasis on early detection tests has fuelled market growth. For example, WHO assists Member States in creating and implementing cancer early detection and screening programs based on screening feasibility and cost-effectiveness assessments, as well as necessary capacity to avoid delays in diagnosis and treatment. The entire need for multi-cancer early detection testing is predicted to increase significantly.
Early Cancer Detection Market Key Developments:
- In September 2023, Point32Health and GRAIL, LLC., announced the expansion of their pilot to offer Galleri, an early cancer detection test created by GRAIL
- In May 2023, Lucence Health Inc. announced the debut of LucenceINSIGHT, an early cancer detection blood test in the U.S
Early Cancer Detection Market Summary
Study Period
2024-2030
Base Year
2023
CAGR
13.1%
Largest Market
Asia Pacific
Fastest Growing Market
North America
Early Cancer Detection Market Dynamics
The early cancer detection market is expected to offer lucrative opportunities due to an increase in the prevalence of many cancers and a greater demand for efficient ways to detect them at an early stage to provide timely and appropriate treatment. For instance, the International Agency for Research on Cancer (IARC) & World Health Organization (WHO) predicts approximately 35 million new cancer cases in 2050, up 77% from the expected 20 million cases in 2022. The fast-increasing worldwide cancer burden reflects both population aging and expansion, as well as changes in people's exposure to risk factors, some of which are linked to socioeconomic development. Tobacco, alcohol, and obesity are important causes driving the increased prevalence of cancer, with pollution in the environment remaining a key driver. Furthermore, the research and laboratory and diagnostic laboratories segments are likely to generate the most profitable applications in the early cancer detection market. Numerous significant companies are delivering early cancer detection diagnostic tests in various laboratories at affordable pricing compared to hospitals. Furthermore, the increased focus on multi-cancer early detection activities has boosted the market expansion.
North-America Got Significant Share
Early Cancer Detection Market Regional Analysis
Based on regions, the market is segmented into North America, Europe, Asia-Pacific, Latin America, and Middle East and Africa. The North American early cancer detection market is estimated to have a large share in 2023 due to high cancer prevalence, rapid technological improvements, and the presence of many supportive government initiatives in the region. It is led by the United States, due to significant investments and the existence of multiple biotechnology businesses producing breakthrough early cancer detection tests. Several organizations, like the American Society of Clinical Oncology (ASCO), encourage the use of early detection products, which is expected to increase revenue in this sector.
Latin America
Europe
Asia Pacific
Middle East
North America
Early Cancer Detection Market Segmentation
By Type
By End User
- Hospitals
- Diagnostic Laboratories
- Others
Geography
- North America
- Europe
- The Asia Pacific
- Latin America
- MEA
Frequently Asked Questions
The Early Cancer Detection Market was valued at USD 955.3 million in 2023 and is expected to create an opportunity of around US$ 1,200 Million in 2030.
The key factors driving the market are multi-cancer early detection in hospitals and laboratory sectors.
Breakthrough technologies for early cancer detection, as well as government support and investment in these sectors, have driven market expansion.
Market research is segmented based on type, end user and region.
North America is estimated to Fastest growing with the highest CAGR over the forecast period.
Key Features of the Reports
- The early cancer detection market report provides granular level information about the Market size, regional Market share, historic Market (2019-2023), and forecast (2024-2030)
- The report covers in-detail insights about the competitor’s overview, company share analysis, key Market developments, and key strategies.
- The report outlines drivers, restraints, unmet needs, and trends that are currently affecting the Market.
- The report tracks recent innovations, key developments, and start-up details that are actively working in the Market.
- The report provides a plethora of information about Market entry strategies, regulatory framework, and reimbursement scenarios.
| 1.Executive Summary |
| 2.Global Early Cancer Detection Market Introduction |
| 2.1.Global Early Cancer Detection Market - Taxonomy |
| 2.2.Global Early Cancer Detection Market - Definitions |
| 2.2.1. Type |
| 2.2.2. End User |
| 2.2.3.Region |
| 3.Global Early Cancer Detection Market Dynamics |
| 3.1. Drivers |
| 3.2. Restraints |
| 3.3. Opportunities/Unmet Needs of the Market |
| 3.4. Trends |
| 3.5. Product Landscape |
| 3.6. New Product Launches |
| 3.7. Impact of COVID 19 on Market |
| 4.Global Early Cancer Detection Market Analysis, 2019 - 2023 and Forecast 2024 - 2030 |
| 4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) |
| 4.3. Market Opportunity Analysis |
| 5.Global Early Cancer Detection Market By Type, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
| 5.1. Liquid Biopsy |
| 5.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 5.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.1.3. Market Opportunity Analysis |
| 5.2. Gene Panel |
| 5.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 5.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.2.3. Market Opportunity Analysis |
| 5.3. Laboratory-developed test (LDT) |
| 5.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 5.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.3.3. Market Opportunity Analysis |
| 5.4. Others |
| 5.4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 5.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.4.3. Market Opportunity Analysis |
| 6.Global Early Cancer Detection Market By End User, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
| 6.1. Hospitals |
| 6.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 6.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.1.3. Market Opportunity Analysis |
| 6.2. Diagnostic Laboratories |
| 6.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 6.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.2.3. Market Opportunity Analysis |
| 6.3. Others |
| 6.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 6.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.3.3. Market Opportunity Analysis |
| 7.Global Early Cancer Detection Market By Region, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
| 7.1. North America |
| 7.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 7.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.1.3. Market Opportunity Analysis |
| 7.2. Europe |
| 7.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 7.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.2.3. Market Opportunity Analysis |
| 7.3. Asia Pacific (APAC) |
| 7.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 7.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.3.3. Market Opportunity Analysis |
| 7.4. Middle East and Africa (MEA) |
| 7.4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 7.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.4.3. Market Opportunity Analysis |
| 7.5. Latin America |
| 7.5.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 7.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.5.3. Market Opportunity Analysis |
| 8.North America Early Cancer Detection Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
| 8.1. Type Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 8.1.1.Liquid Biopsy |
| 8.1.2.Gene Panel |
| 8.1.3.Laboratory-developed test (LDT) |
| 8.1.4.Others |
| 8.2. End User Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 8.2.1.Hospitals |
| 8.2.2.Diagnostic Laboratories |
| 8.2.3.Others |
| 8.3. Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 8.3.1.United States of America (USA) |
| 8.3.2.Canada |
| 9.Europe Early Cancer Detection Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
| 9.1. Type Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 9.1.1.Liquid Biopsy |
| 9.1.2.Gene Panel |
| 9.1.3.Laboratory-developed test (LDT) |
| 9.1.4.Others |
| 9.2. End User Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 9.2.1.Hospitals |
| 9.2.2.Diagnostic Laboratories |
| 9.2.3.Others |
| 9.3. Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 9.3.1.Germany |
| 9.3.2.France |
| 9.3.3.Italy |
| 9.3.4.United Kingdom (UK) |
| 9.3.5.Spain |
| 10.Asia Pacific (APAC) Early Cancer Detection Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
| 10.1. Type Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 10.1.1.Liquid Biopsy |
| 10.1.2.Gene Panel |
| 10.1.3.Laboratory-developed test (LDT) |
| 10.1.4.Others |
| 10.2. End User Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 10.2.1.Hospitals |
| 10.2.2.Diagnostic Laboratories |
| 10.2.3.Others |
| 10.3. Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 10.3.1.China |
| 10.3.2.India |
| 10.3.3.Australia and New Zealand (ANZ) |
| 10.3.4.Japan |
| 10.3.5.Rest of APAC |
| 11.Middle East and Africa (MEA) Early Cancer Detection Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
| 11.1. Type Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 11.1.1.Liquid Biopsy |
| 11.1.2.Gene Panel |
| 11.1.3.Laboratory-developed test (LDT) |
| 11.1.4.Others |
| 11.2. End User Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 11.2.1.Hospitals |
| 11.2.2.Diagnostic Laboratories |
| 11.2.3.Others |
| 11.3. Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 11.3.1.GCC Countries |
| 11.3.2.South Africa |
| 11.3.3.Rest of MEA |
| 12.Latin America Early Cancer Detection Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
| 12.1. Type Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 12.1.1.Liquid Biopsy |
| 12.1.2.Gene Panel |
| 12.1.3.Laboratory-developed test (LDT) |
| 12.1.4.Others |
| 12.2. End User Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 12.2.1.Hospitals |
| 12.2.2.Diagnostic Laboratories |
| 12.2.3.Others |
| 12.3. Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 12.3.1.Brazil |
| 12.3.2.Mexico |
| 12.3.3.Rest of LA |
| 13. Competition Landscape |
| 13.1. Market Player Profiles (Introduction, Brand/Product Sales, Financial Analysis, Product Offerings, Key Developments, Collaborations, M & A, Strategies, and SWOT Analysis) |
| 13.2.1.Anchor Dx |
| 13.2.2.Elypta AB |
| 13.2.3.Illumina, Inc. |
| 13.2.4.Foundation Medicine, Inc. |
| 13.2.5.Freenome Holdings, Inc. |
| 13.2.6.Genecast |
| 13.2.7.Exact Sciences Corporation |
| 13.2.8.Burning Rock DX |
| 13.2.9.Micronoma, Inc. |
| 14. Research Methodology |
| 15. Appendix and Abbreviations |
- Anchor Dx
- Elypta AB
- Illumina, Inc.
- Foundation Medicine, Inc.
- Freenome Holdings, Inc.
- Genecast
- Exact Sciences Corporation
- Burning Rock DX
- Micronoma, Inc.